StockData
LFWDNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31

Lifeward Ltd.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$5.93−0.07 (-1.17%)

Close on Oct 19, 2026

Market cap
$16.58M
P/E (TTM)
–
Dividend yield
–

Earnings

Next report expected Nov 13, 2026, before market open (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Aug 14, 2026Before market open$6.60M$-4.12$-1.46
Q1 FY2026
Ended Mar 31, 2026
May 15, 2026Before market open$3.90M$-6.70$-3.13
Q4 FY2025
Ended Dec 31, 2025
Mar 18, 2026Before market open$5.10M$-3.60$-2.85
Q3 FY2025
Ended Sep 30, 2025
Nov 14, 2025Before market open$6.20M$-0.20$-0.19
Q2 FY2025
Ended Jun 30, 2025
Aug 14, 2025Before market open$5.70M$-0.58$-0.31
Q1 FY2025
Ended Mar 31, 2025
May 15, 2025Before market open$5.00M$-0.46$-0.44
Q4 FY2024
Ended Dec 31, 2024
Mar 7, 2025Before market open$7.50M$-1.73$-0.38
Q3 FY2024
Ended Sep 30, 2024
Nov 12, 2024Before market open$6.10M$-0.35$-0.45
Q2 FY2024
Ended Jun 30, 2024
Aug 15, 2024Before market open–––
Q1 FY2024
Ended Mar 31, 2024
May 15, 2024Before market open–––
Q4 FY2023
Ended Dec 31, 2023
Feb 27, 2024Before market open–––

Company guidance

Outlook given with results on Nov 14, 2025, compared with the previous outlook

MeasurePeriodGuidancevs. prior
projected non-GAAP net lossnon-GAAPfull-year 2025$12.00M to $14.00MRaised
expected revenuefull-year 2025$24.00M to $26.00MMaintained

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Lifeward filed with the SEC